Thiazolidinedione Use and Bone Loss in Older Diabetic Adults

Authors

Ann Schwartz

Published

April 12, 2006

Abstract

Context: Activation of peroxisome proliferator-activated receptor-γ by thiazolidinediones (TZDs) results in lower bone mass in mice.

Supporters

Support the authors with ResearchCoin

Journal

The Journal of Clinical Endocrinology & Metabolism

Topics

DOI

10.1210/jc.2005-2226

Thiazolidinedione Use and Bone Loss in Older Diabetic Adults

Authors

Ann Schwartz

Published

April 12, 2006

Abstract

Context: Activation of peroxisome proliferator-activated receptor-γ by thiazolidinediones (TZDs) results in lower bone mass in mice.

Supporters

Support the authors with ResearchCoin

Journal

The Journal of Clinical Endocrinology & Metabolism

Topics

DOI

10.1210/jc.2005-2226

Paper

Paper

Paper

Paper

Thiazolidinedione Use and Bone Loss in Older Diabetic Adults

Abstract

Supporters

Journal

Topics

DOI

Thiazolidinedione Use and Bone Loss in Older Diabetic Adults

Abstract

Supporters

Journal

Topics

DOI